Alkem Laboratories Limited
ALKEM.NS
₹5325.00
▼ 2.28%
Alkem Laboratories slipped 2.28% to Rs 5,325 as investors digested a soft March-quarter print even as the company hosts its Q1FY27 earnings call with Motilal Oswal later today. Net profit for Q4FY26 had fallen 22.7% year-on-year to Rs 236 crore, dragged down by an exceptional gratuity and leave liability charge of Rs 60.27 crore, though full-year FY26 revenue grew a healthier 13.5% to Rs 14,712 crore with a record EBITDA of Rs 3,005 crore. The board has recommended a final dividend of Rs 10 per share, with the record date having passed on August 7. Despite today's dip, Nomura continues to back the stock with a Buy rating and a target of Rs 6,890, well above current levels, with the stock trading at a P/E of around 25.6 times within its 52-week range of Rs 4,716 to Rs 5,933.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| -0.82% | -3.39% | 7.71% | 13.15% |
No comments:
Post a Comment